BASG – Federal Office for Safety in Health Care
AGES MEA – Austrian Medicines and Medical Devices Agency
The Federal Office for Safety in Health Care – BASG and the Austrian Medicines and Medical Devices Agency – AGES MEA were set up in January 2006. Their responsibilities include a variety of tasks such as issuing marketing authorization for medicinal products (human and veterinary), assessing the efficacy and safety of medicinal products and medical devices, market surveillance, inspection of manufacturers.
The BASG is directly subordinated to the Austrian Federal Ministry of Health – BMG and thus carries out sovereign tasks. It consists of three members appointed by the Federal Minister of Health.
Fully owned by the Republic of Austria, the AGES MEA is closely linked to the BASG providing it with necessary resources (staff and facilities). When carrying out sovereign activities, the employees of AGES MEA are acting on behalf of the Federal Office for Safety in Health Care BASG.
Contact
Address Traisengasse 5 Vienna, 1200 Austria
Tel +43 (0) 50 555 -25000
Website http://www.basg.gv.at/en/home/https://www.ages.at/en/healthy-life-for-humans-animals-and-plants/
Email presse@ages.at
Several macro-trends affected the pharmaceutical industry in 2022, impacting its inventory position, writes Matthew Bardell, managing director of specialist inventory consultants nVentic. Bardell highlights findings in a recent report –…
In conversation with PharmaBoardroom Christoph Stoller and Adrian Van den Hoven of Medicines for Europe, the association representing the European generics, biosimilar and value-added-medicines industry, highlighted their members’ rapid response…
The editorial team at Panorama Farmaceutico explain why coordinated action is needed within Brazilian pharma to reduce dependence on API imports from abroad and increase medical sovereignty. * The…
Xavier De Cuyper introduces the Federal Agency for Medicines & Health Products (FAMHP) and the essential role it plays in Belgium’s healthcare regulatory framework since being founded in 2007. De…
Rafael Gual Cosío, director general of the Cámara Nacional de la Industria Farmacéutica (CANIFARMA), the umbrella industry association for the healthcare sector in Mexico, shares his perspectives on the complex…
Medicine shortages are a European-wide issue. In 2016, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) formed a task force to investigate availability issues, including medicines that are…
Tomáš Votruba of the Association of Full-Line Wholesalers (AVEL), which gathers the three major players of the pharmaceutical distribution market in the Czech Republic, gives an overview of the current…
Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of geopolitical and bureaucratic issues are restricting the flow of…
The Czech Republic’s Minister of Health, Adam Vojtěch, is the youngest in the country’s history and has set out an ambitious reform programme to improve the state of the Czech…
Like many of its European counterparts, Hungary is suffering from medicine shortages. Vaccines, vitamins, and orphan drugs are some of the most affected areas and oncology patients are now also…
Christoph Stoller, general manager for Austria and Germany at Teva was recently elected president of Medicines for Europe, the continent-wide association for the generics and biosimilars industries. Stoller plans to…
Christoph Stoller, the recently appointed president of Medicines for Europe, outlines the mission of his presidency, how the association and its members are working to tackle the issue of drug…
See our Cookie Privacy Policy Here
